Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : ZIMLABBSE : 541400ISIN CODE : INE518E01015Industry : Pharmaceuticals & DrugsHouse : MNC

BSE111.002.4 (+2.21 %)

PREV CLOSE ( ) 108.60

OPEN PRICE ( ) 114.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8721

TODAY'S LOW / HIGH ( )108.70 114.00

52 WK LOW / HIGH ( )59.72 126.95

NSE111.66-1.39 (-1.23 %)

PREV CLOSE( ) 113.05

OPEN PRICE ( ) 113.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 74288

TODAY'S LOW / HIGH( ) 110.10 115.00

52 WK LOW / HIGH ( )59.31 127

Chairman	Anwar Siraj Daud
Managing Director	Anwar Siraj Daud
Company Secretary	Piyush Siddeshwar Nikhade
Whole Time Director - Finance	Zulfiquar Murtaza Kamal
Non Executive Independent Director	Kavita Loya Padmakar Shrinivas Joshi Kamlesh Shende Ashok Bhatia
Whole Time Director	Niraj Pukhraj Dhadiwal Prakash Pralhadrao Sapkal

Incorporation Year : 1984

Registered Office :

Address : Sadoday Gyan (Ground Floor),Opp. Nadt, Nelson Square, Nagpur,
Maharashtra-440013 .

Phone : 0712-2981960

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE